131 related articles for article (PubMed ID: 19185829)
1. Tibolone: the risk is too high.
Goodwin PJ
Lancet Oncol; 2009 Feb; 10(2):103-4. PubMed ID: 19185829
[No Abstract] [Full Text] [Related]
2. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.
Kenemans P; Bundred NJ; Foidart JM; Kubista E; von Schoultz B; Sismondi P; Vassilopoulou-Sellin R; Yip CH; Egberts J; Mol-Arts M; Mulder R; van Os S; Beckmann MW;
Lancet Oncol; 2009 Feb; 10(2):135-46. PubMed ID: 19167925
[TBL] [Abstract][Full Text] [Related]
3. Progestins and recurrence in breast cancer survivors.
Chlebowski RT; Anderson GL
J Natl Cancer Inst; 2005 Apr; 97(7):471-2. PubMed ID: 15812065
[No Abstract] [Full Text] [Related]
4. What have we really learned from 'LIBERATE' trial?
Dimitrakakis C; Tsigginou A; Keramopoulos D; Antsaklis A
Maturitas; 2010 May; 66(1):99-100. PubMed ID: 20236777
[TBL] [Abstract][Full Text] [Related]
5. Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.
Baber R; Hickey M; Kwik M
Drug Saf; 2005; 28(12):1085-100. PubMed ID: 16329712
[TBL] [Abstract][Full Text] [Related]
6. Tibolone and breast cancer.
Prescrire Int; 2010 Dec; 19(111):281. PubMed ID: 21355381
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy in breast cancer survivors.
Kandil M
Climacteric; 2010 Oct; 13(5):499. PubMed ID: 20738237
[No Abstract] [Full Text] [Related]
8. Menopausal hormone therapy after breast cancer: the Stockholm randomized trial.
von Schoultz E; Rutqvist LE;
J Natl Cancer Inst; 2005 Apr; 97(7):533-5. PubMed ID: 15812079
[TBL] [Abstract][Full Text] [Related]
9. What happened to WHI: menopausal hormonal therapy in 2012.
Hansen KA; Eyster KM
Clin Obstet Gynecol; 2012 Sep; 55(3):706-12. PubMed ID: 22828102
[TBL] [Abstract][Full Text] [Related]
10. [Hormone replacement therapy in patients after breast cancer].
Köninger A; Kümmel S; Kimmig R
MMW Fortschr Med; 2008 Oct; 150(43):32-4. PubMed ID: 19025144
[No Abstract] [Full Text] [Related]
11. Tibolone: the way to beat many a postmenopausal ailments.
Lazovic G; Radivojevic U; Marinkovic J
Expert Opin Pharmacother; 2008 Apr; 9(6):1039-47. PubMed ID: 18377345
[TBL] [Abstract][Full Text] [Related]
12. Menopausal hormone therapy (HT) in patients with breast cancer.
Batur P; Blixen CE; Moore HC; Thacker HL; Xu M
Maturitas; 2006 Jan; 53(2):123-32. PubMed ID: 16368466
[TBL] [Abstract][Full Text] [Related]
13. The LIBERATE tibolone trial in breast cancer survivors.
Speroff L
Maturitas; 2009 May; 63(1):1-3. PubMed ID: 19327923
[No Abstract] [Full Text] [Related]
14. Hormone replacement therapy and nonhormonal control of menopausal symptoms in breast cancer survivors.
Cobleigh MA
Cancer Treat Res; 1998; 94():209-30. PubMed ID: 9587690
[No Abstract] [Full Text] [Related]
15. Hormone replacement therapy in women with a history of breast cancer.
Ylikorkala O; Metsä-Heikkilä M
Gynecol Endocrinol; 2002 Dec; 16(6):469-78. PubMed ID: 12626034
[TBL] [Abstract][Full Text] [Related]
16. Spanish Menopause Society position statement: use of tibolone in postmenopausal women.
Mendoza N; Abad P; Baró F; Cancelo MJ; Llaneza P; Manubens M; Quereda F; Sánchez-Borrego R
Menopause; 2013 Jul; 20(7):754-60. PubMed ID: 23793166
[TBL] [Abstract][Full Text] [Related]
17. Patient information. Treating menopausal symptoms.
Am Fam Physician; 2010 Oct; 82(7):809-10. PubMed ID: 20879704
[No Abstract] [Full Text] [Related]
18. [Hormone therapy and risk for breast cancer in Finnish postmenopausal women].
Lyytinen H; Ylikorkala O
Duodecim; 2011; 127(3):235-42. PubMed ID: 21438346
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy for breast cancer survivors: an answered question?
Zielinski SL
J Natl Cancer Inst; 2005 Jul; 97(13):955. PubMed ID: 15998945
[No Abstract] [Full Text] [Related]
20. Tibolone: cancers of the breast and endometrium.
Prescrire Int; 2006 Jun; 15(83):107. PubMed ID: 16764100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
